Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

NCT03941587 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Polypoidal Choroidal Vasculopathy

Interventions

DRUG: Aflibercept + reduced fluence photodynamic therapy (RF-PDT)
DRUG: Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT)

Sponsor

Singapore National Eye Centre

Collaborators

[object Object]
[object Object]